Meridian Bioscience Inc. (VIVO): $20.39

-0.59 (-2.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Meridian Bioscience Inc (VIVO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Meridian Bioscience Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $34 $25 $29.67 $20.88 42.1%

The Trend in the Analyst Price Target


Over the past 127 days, VIVO's average price target has gone up $3.

VIVO reports an average of 38.7% for its upside potential over the past 13 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 3 34 25.00 29.67 20.65 43.68%
2021-06-05 3 34 30.00 32.00 18.89 69.4%
2021-05-22 3 34 30.00 32.00 19.51 64.02%
2021-05-15 3 34 30.00 32.00 19.07 67.8%
2021-05-08 3 34 32.00 32.67 20.45 59.76%
2021-04-25 3 34 32.00 32.67 21.96 48.77%
2021-04-17 3 34 32.00 32.67 23.25 40.52%
2021-04-10 3 34 32.00 32.67 25.04 30.47%
2021-04-03 3 34 32.00 32.67 28.30 15.44%
2021-03-20 3 34 32.00 32.67 25.75 26.87%
2021-03-13 3 34 32.00 32.67 23.76 37.5%
2021-03-06 3 34 32.00 32.67 21.91 49.11%
2021-02-27 3 37 32.00 34.33 21.08 62.86%
2021-02-20 3 37 34.00 35.00 24.04 45.59%
2021-02-13 3 37 34.00 35.00 29.82 17.37%
2021-02-06 3 30 24.00 26.67 29.02 -8.1%
2021-01-30 3 30 24.00 26.67 22.10 20.68%
2021-01-23 3 30 24.00 26.67 22.97 16.11%
2021-01-16 3 30 24.00 26.67 21.59 23.53%
2021-01-09 3 30 24.00 26.67 21.69 22.96%
2021-01-02 3 30 24.00 26.67 18.69 42.7%
2020-12-26 3 30 24.00 26.67 20.91 27.55%
2020-12-19 3 30 24.00 26.67 20.66 29.09%
2020-12-09 3 30 24.00 26.67 18.59 43.46%
2020-12-07 3 30 20.75 25.58 18.79 36.14%
2020-11-25 3 30 20.75 25.58 17.76 44.03%
2020-11-13 3 30 20.75 25.58 16.92 51.18%
2020-09-11 3 34 20.75 26.25 15.16 73.15%
2020-08-14 3 34 24.00 27.33 18.14 50.66%
2020-08-07 3 34 19.00 25.67 19.32 32.87%
2020-07-24 2 34 19.00 26.50 23.15 14.47%
2020-05-29 1 19 19.00 19.00 NA NA%

VIVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 2 2 0 0 0 4

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of VIVO is higher than 74.35% of all US stocks.
  • VIVO has a higher number of analysts covering the stock than 27.21% of all US stocks.
  • Meridian Bioscience Inc's average analyst price target is higher than 68.76% of stocks in the small market cap category.
  • VIVO has a lower variance in analysts' estimates than 65.18% of Pharmaceutical Products stocks.

Stocks similar to Meridian Bioscience Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CDAK, SRRA and VECT.

Make investment decisions regarding VIVO using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6647 seconds.